Ensysce Biosciences (ENSCW) Deferred Taxes (2019 - 2021)
Ensysce Biosciences (ENSCW) reported Deferred Taxes of -$61278.0 for Q1 2021, down 586.97% quarter-over-quarter from -$8920.0 in Q4 2019.
Ensysce Biosciences (ENSCW) Deferred Taxes (2019 - 2021) Analysis & Trends
Ensysce Biosciences (ENSCW) has 2 years of Deferred Taxes data on file, last reported at -$61278.0 in Q1 2021.
- Deferred Taxes for Q1 2021 came in at -$61278.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was -$61168.0 (changed N/A YoY), and the FY2019 annual result was -$1764.0, down 200.0% from the prior year.
- Deferred Taxes eased to -$61278.0 in Q1 2021 per ENSCW's latest filing, from -$8920.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $13124.0 in Q2 2019 and troughed at -$61278.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -61,278.00 |
| Dec 31, 2019 | -8,920.00 |
| Sep 30, 2019 | -4,094.00 |
| Jun 30, 2019 | 13,124.00 |
| Mar 31, 2019 | -1,874.00 |